Burzynski Research Institute, Inc.
BZYR · OTC
8/31/2025 | 5/31/2025 | 2/28/2025 | 11/30/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $255 | $270 | $241 | $301 |
| G&A Expenses | $79 | $61 | $51 | $51 |
| SG&A Expenses | $79 | $61 | $51 | $51 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $334 | $331 | $293 | $352 |
| Operating Income | -$334 | -$331 | -$293 | -$352 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $0 | $0 | $0 | $0 |
| Pre-Tax Income | -$334 | -$331 | -$293 | -$352 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$334 | -$331 | -$293 | -$352 |
| % Margin | – | – | – | – |
| EPS | -0.003 | -0.003 | -0.002 | -0.003 |
| % Growth | 0% | -13.6% | 18.5% | – |
| EPS Diluted | -0.003 | -0.003 | -0.002 | -0.003 |
| Weighted Avg Shares Out | 131,448 | 131,448 | 131,448 | 131,448 |
| Weighted Avg Shares Out Dil | 131,448 | 131,448 | 131,448 | 131,448 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | -$371 | $0 |
| EBITDA | -$334 | -$331 | -$664 | -$352 |
| % Margin | – | – | – | – |